According to Grigson, Because our preliminary data suggested that patients did better in the study if they were on both the GLP-1 drug and medication for opioid use disorder, in this study, half of the participants will be on methadone and half will be on buprenorphine for opioid use disorder treatment. Because semaglutide is stronger, is dosed weekly instead of daily, and has fewer gastrointestinal side effects than liraglutide, it may be even more effective in reducing craving while increasing real-world treatment adherence
Neurochemical theories, in edsLiebermanJ
However, its active ingredient, semaglutide, is also present in Wegovy, the GLP-1 medication FDA-approved for weight loss, and available as a compounded medication
10.1038/s42255-024-01068-x 79 RakipovskiG.RolinB.NohrJ.KleweI.FrederiksenK
In fact, the most weight loss ever seen in a diabetes trial in only 40 weeks